An innovative hematopoietic stem cell gene therapy approach benefits CLN1 disease in the mouse model
Abstract Hematopoietic stem and progenitor cells (HSPCs) can establish a long‐lasting microglia‐like progeny in the central nervous system of properly myeloablated hosts. We exploited this approach to treat the severe CLN1 neurodegenerative disorder, which is the most aggressive form of neuronal cer...
Saved in:
| Main Authors: | Marco Peviani, Sabyasachi Das, Janki Patel, Odella Jno‐Charles, Rajesh Kumar, Ana Zguro, Tyler D Mathews, Paolo Cabras, Rita Milazzo, Eleonora Cavalca, Valentina Poletti, Alessandra Biffi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer Nature
2023-03-01
|
| Series: | EMBO Molecular Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.15252/emmm.202215968 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Repurposing of tamoxifen ameliorates CLN3 and CLN7 disease phenotype
by: Chiara Soldati, et al.
Published: (2021-08-01) -
CLN3 disease disrupts very early postnatal hippocampal maturation
by: Jeet B. Singh, et al.
Published: (2025-07-01) -
Evidence of the impact of CLN2 and CLN3 Batten disease on families in the United Kingdom
by: Sara E. Mole, et al.
Published: (2025-05-01) -
Expanded Phenotype of the <i>Cln6<sup>nclf</sup></i> Mouse Model
by: Victoria Chaoul, et al.
Published: (2025-04-01) -
Defective anterograde protein-trafficking contributes to endoplasmic reticulum-stress in a CLN1 disease model
by: Nisha Plavelil, et al.
Published: (2025-06-01)